Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

GRANDE PHARMACIE MINERVOISE : revenue, balance sheet and financial ratios

GRANDE PHARMACIE MINERVOISE is a French company founded 5 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in OLONZAC (34210), this company of category PME shows in 2025 a net income positive of 261 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE MINERVOISE (SIREN 883020885)
Indicator 2025 2024 2022 2021
Revenue N/C N/C N/C N/C
Net income 261 372 € 250 697 € 298 448 € 169 600 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2025, GRANDE PHARMACIE MINERVOISE generates positive net income of 261 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 170 k€ -> 261 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

261 372 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 42%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

42.357%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

59.274%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

30.8%

Solvency indicators evolution
GRANDE PHARMACIE MINERVOISE

Sector positioning

Debt ratio
42.36 2025
2022
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good -8 pts over 3 years

In 2025, the debt ratio of GRANDE PHARMACIE MINERVOISE (42.36) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
59.27% 2025
2022
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good +16 pts over 3 years

In 2025, the financial autonomy of GRANDE PHARMACIE MINERVOISE (59.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 116.79. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

116.789

Liquidity indicators evolution
GRANDE PHARMACIE MINERVOISE

Sector positioning

Liquidity ratio
116.79 2025
2022
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch

In 2025, the liquidity ratio of GRANDE PHARMACIE MINERVOISE (116.79) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of GRANDE PHARMACIE MINERVOISE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of GRANDE PHARMACIE MINERVOISE is estimated at 4 151 925 € (range 2 817 516€ - 6 514 942€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2817k€ 4151k€ 6514k€
4 151 925 € Range: 2 817 516€ - 6 514 942€
NAF 5 année 2025

Valuation method used

Net Income Multiple
261 372 € × 15.9x = 4 151 925 €
Range: 2 817 516€ - 6 514 943€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE MINERVOISE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE MINERVOISE

What is the revenue of GRANDE PHARMACIE MINERVOISE ?

The revenue of GRANDE PHARMACIE MINERVOISE is not publicly disclosed (confidential accounts filed with INPI).

Is GRANDE PHARMACIE MINERVOISE profitable?

Yes, GRANDE PHARMACIE MINERVOISE generated a net profit of 261 k€ in 2025.

Where is the headquarters of GRANDE PHARMACIE MINERVOISE ?

The headquarters of GRANDE PHARMACIE MINERVOISE is located in OLONZAC (34210), in the department Herault.

Where to find the tax return of GRANDE PHARMACIE MINERVOISE ?

The tax return of GRANDE PHARMACIE MINERVOISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE MINERVOISE operate?

GRANDE PHARMACIE MINERVOISE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.